Kiadis Pharma N.V.
New Filing
CIK: 0001780328·Biotechnology·NETHERLANDS·Filed: Jun 26, 2019
Total Offering
$18,352,460
Amount Sold
$18,352,460
Investors
25
First Sale
Jun 5, 2019
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Year Incorporated
- 2015
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Mark Wegter | Related Person |
| Berndt Modig | Related Person |
| Martijn Kleijwegt | Related Person |
| Dr. Robert Soiffer | Related Person |
| Otto Schwarz | Related Person |
| Subhanu Saxena | Related Person |
| Arthur Lahr | Related Person |
| Scott A. Holmes | Related Person |
| James Joy | Related Person |
| Mark Schaefer | Related Person |
Company
SEC Filing
0001567619-19-014020
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free